Formation Bio
Chelsea Colby has extensive experience in operations and management within the healthcare and tech sectors. Currently serving as Director of Site Identification and Study Startup at Formation Bio, Chelsea Colby is responsible for developing strategies to enhance site startup speed while upholding quality standards. Previous roles include Manager of Clinical Operations at Imagen Technologies, where efficiency in x-ray pathology identification improved significantly, and Senior Director of Operations at LaaSie.AI, where quarterly churn was notably reduced. Chelsea Colby's background encompasses leadership of diverse teams, implementation of process improvements, and collaboration with cross-functional departments to drive operational excellence. Educational credentials include an MBA in Sustainability Studies from NYU Stern School of Business and a B.S. in Hotel Administration from Cornell University.
This person is not in any teams
Formation Bio
5 followers
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.